Global External Ventricular Drain Market – Industry Trends and Forecast to 2031

Global External Ventricular Drain Market, By Product Type (Ventricular Drainage Set and Accessories), Indication Analysis (Posterior Fossa Tumor, Hematomas Posterior Fossa, IV Ventricle Obstruction, Cranial Injuries, Subdural Hematomas, Meningitis, Subarachnoid Hemorrhage into CSF and Other), Application (Hydrocephalus, Reye Syndrome, Subarachnoid Haemorrhage, Traumatic Brain Injury, and Others), End-User (Hospitals, Specialty Hospitals, Specialty Clinics, and Others) – Industry Trends and Forecast to 2031.

External Ventricular Drain Market Analysis and Size

According to the recent data among the different types of childhood brain tumors, their incidence ranges from 1 to 3 per 100,000. Childhood neoplasms occur in the infratentorial region in about 54% to 70% of pediatric brain tumors, whereas in the adult population, it is about 15% to 20%.

Data Bridge Market Research analyzes that the global external ventricular drain market which was USD 2,777.28 million in 2023, will reach USD 4,166.25 million by 2031, and is expected to undergo a CAGR of 5.2% during the forecast period. “Ventricular drainage set" dominates the product type segment of the disabled assistive devices market owing to the rise in the incidence and recurrence of traumatic and hydrocephalus brain injury. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

External Ventricular Drain (EVD), also referred to as an external ventricular drainage (EVD) system or a ventriculostomy is used in neurosurgery to remove Extra Cerebrospinal Fluid (CSF) from the ventricles of the brain. A small hole is often bored in the skull to implant a thin, flexible catheter into one of the ventricles of the brain. This procedure is known as an external ventricular drain. The excess CSF can be drained from the brain and collected in a drainage bag or container due to the catheter's connection to an external drainage system. In order to gauge and keep track of the intracranial pressure, the drainage system might also have pressure monitoring capabilities.

Global External Ventricular Drain Market Dynamics

Drivers

• Increasing Prevalence of Neurologic Disorders

Globally, neurological conditions such hydrocephalus, subarachnoid haemorrhage, and traumatic brain damage continue to be major health concerns. The need for EVDs, a critical neurosurgery procedure for controlling elevated intracranial pressure, is driven by these disorders' increasing incidence and prevalence.

• Rising Geriatric Population

The ageing of the golbal population is a major market driver for EVD. The likelihood of neurological illnesses and ailments linked to elevated intracranial pressure, such hydrocephalus, tends to grow as people age. The rising elderly population influences the demand for EVD devices as a critical therapeutic option.

• Increasing Focus on Personalized Medicine

Personalised personalized and genomic medicine development opens the door tocustomized treatment modalities in neurosurgery. By identifying specific risk factors, forecasting therapy effectiveness, and creating personalised EVD management plans, the integration of genetic profiling and precision medicine techniques with EVD procedures can improve patient outcomes.

Opportunities

• Growing Demand for Minimally Invasive Procedures

In many medical specialties, including neurosurgery, minimally invasive surgical methods are becoming more popular. Minimally invasive techniques can be used to execute EVD procedures, which has advantages such as less traumatic surgery, shorter hospital stays, and quicker recovery. The popularity of EVDs is driven by the rising need for less invasive procedures.

• Rising Technological Advancements

Improved EVD devices and related accessories have been developed as a result of developments in medical technology. The use of materials that lower the risk of infection, inventive catheter designs, and improved monitoring capabilities are a few examples of these improvements. Technological advancements can spur market expansion by enhancing EVD operations' overall safety and efficacy as well as patient outcomes.

• Increasing Healthcare Expenditure

The expansion of healthcare infrastructure and the general rise in healthcare spending globally both contribute to the expansion of the EVD market. Particularly in poorer countries, more access to cutting-edge medical technologies and procedures, including EVDs, is made possible by higher healthcare spending.

Restraints/Challenges

• Strict Regulations

It can be difficult to meet the legal and compliance standards for EVDs. In order to secure the required permissions and make sure their products fulfill safety and quality requirements, manufacturers must traverse regulatory systems. Regulations are always changing, which increases complexity and may delay the launch of new products.

• Reimbursement plans

Various healthcare systems and nations may have various reimbursement guidelines and insurance coverage for EVD operations and devices. The pricing and accessibility of EVDs might be impacted by inconsistent or limited reimbursement, which can put obstacles in the way of healthcare professionals and patients.

• High Cost of EVDs

Particularly when taking into account the requirement for routine maintenance and replacement, the cost of EVD devices and related processes might be substantial. Cost restrictions in healthcare systems and restricted reimbursement coverage may have an impact on EVD adoption and market expansion.

This external ventricular drain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the External Ventricular Drain market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In August 2022, Brain Navi Biotechnology announced that NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the United States Food and Drug Administration (USFDA) for clearance by the end of 2022. The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi Medical Center, with the External Ventricular Drain (EVD).
• In June 2019, Integra LifeSciences took over Arkis Biosciences Inc. which offers a range of neurosurgical equipment’s, such as the CerebroFlo EVD catheter with Endexo technology, a perpetual additive intended to reduce the probability for catheter obstacle due to thrombus creation.

Global External Ventricular Drain Market Scope

The external ventricular drain market is segmented on the basis of product type, indication analysis, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product type

• Ventricular drainage sets
• Accessories

Indication Analysis

• Posterior fossa tumor
• Hematomas posterior fossa
• IV ventricle obstruction
• Cranial injuries
• Subdural hematomas
• Meningitis
• Subarachnoid haemorrhage into CSF
• Others

Application

• Hydrocephalus
• Reye syndrome
• Subarachnoid haemorrhage
• Traumatic brain injury
• Others

End-User

• Hospitals
• Speciality hospitals
• Speciality clinics
• Others

Global External Ventricular Drain Market Regional Analysis/Insights

The global external ventricular drain market is analysed and market size insights and trends are provided by country, product type, indication analysis, application, and end-user as referenced above.

The countries covered in the external ventricular drain market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.

North America dominates the global external ventricular drain market due to rise in the prevalence of traumatic brain injuries. Furthermore, the increase in the incidence of neurovascular disorders will further boost the growth of the external ventricular drain market in the region during the forecast period.   

Middle East and Africa is the fastest-growing region due to the rise in the incidence of such a huge patient base in the advancing countries, and the growth of healthcare expenditures is further anticipated to propel the growth of the external ventricular drain market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The external ventricular drain market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the external ventricular drain market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the external ventricular drain market.

Competitive Landscape and External Ventricular Drain Market Share Analysis

The external ventricular drain market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the external ventricular drain market are:

• Berlin Heart (Berlin)
• Terumo Corporation (Japan)
• ABIOMED (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Abbott (U.S.)
• Getinge AB (Sweden)
• Evaheart, Inc.(U.S.)
• Neuromedex GmbH (Germany)
• Medtronic (U.S.)
• Sophysa (France)
• Dispomedica GmbH (Germany)
• Fuji Systems (Japan)
• Integra LifeSciences Corporation (U.S.)
• B. Braun Melsungen AG (Germany)
• SILMAG S.A. (Argentina)
• Moller Medical GmbH (Germany)
• Zebra Technologies Corp. (U.S.)
• Arkis BioSciences Inc. (U.S.)
• Shandong Freda Medical Device Co., Ltd. (China)